Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer
Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer
About this item
Full title
Author / Creator
Publisher
Berlin: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Berlin: Springer
Subjects
More information
Scope and Contents
Contents
Capecitabine (Xeloda) is a novel, oral fluoropyrimidine carbamate rationally designed to generate 5-fluorouracil (5-FU) preferentially in tumor tissue via a three-step enzymatic cascade.
The objective of this study was to compare the pharmacokinetics of capecitabine and its metabolites in Japanese and Caucasian cancer patients.
The study incl...
Alternative Titles
Full title
Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_213544953
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_213544953
Other Identifiers
ISSN
0344-5704
E-ISSN
1432-0843
DOI
10.1007/s00280-003-0642-8
